Target intelligence / Profile preview

Calcium/calmodulin-dependent protein kinase type IV (CAMK4)

Target
CAMK4
Molecular classification
Enzyme, Kinase, Serine/threonine-protein kinase
01

Overview

Calcium/calmodulin-dependent protein kinase type IV (CAMK4) is a multifunctional serine/threonine kinase that operates as a key effector in calcium-triggered signaling cascades. Upon activation by calcium/calmodulin binding and phosphorylation by upstream CaMKKs, CAMK4 translocates to the nucleus where it phosphorylates transcription factors such as CREB and CREM, thereby regulating gene expression crucial for immune response, synaptic plasticity, and cell survival. In the immune system, CAMK4 is a critical driver of T-cell activation, Th17 cell differentiation, and osteoclastogenesis. Consequently, its overactivation is strongly implicated in the pathogenesis of autoimmune and inflammatory disorders, including systemic lupus erythematosus (SLE), lupus nephritis, and rheumatoid arthritis (RA). Additionally, CAMK4 dysregulation in the central nervous system is linked to neurological conditions such as depression and autism spectrum disorder. Although there are currently no selective CAMK4 inhibitors approved for clinical use, preclinical studies using tool compounds like KN-93 and cell-targeted nanoparticle delivery systems have shown great promise in mitigating autoimmune pathology and kidney damage, highlighting CAMK4 as a highly attractive therapeutic target.

Other names
CaMK IVCaMK-GRCaMK4Calcium/calmodulin-dependent protein kinase IVCaM kinase-GR
02

Mechanism of action

Inhibition of kinase activity, typically through ATP-competitive or allosteric mechanisms, which blocks downstream phosphorylation of transcription factors like CREB and CREM.

03

Biological functions

Signal transductionTranscription regulationImmune responseCell survivalSynaptic plasticityT-cell activationTh17 cell differentiationOsteoclastogenesis
04

Disease associations

InflammationAutoimmune diseaseSystemic lupus erythematosusRheumatoid arthritisDepressionAutism spectrum disorderKidney diseaseLupus nephritis
05

Safety considerations

Systemic immunosuppressionCognitive impairment or memory deficits due to role in hippocampal long-term potentiationOff-target cardiovascular effects (e.g., potassium channel inhibition associated with some tool compounds like KN-93)
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

CAMK4 mRNA expressionIL-17 levelsIL-2 levelsCREB phosphorylationBCL6 expression

Beyond the preview

Go deeper on Calcium/calmodulin-dependent protein kinase type IV (CAMK4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium/calmodulin-dependent protein kinase type IV (CAMK4).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call